140 related articles for article (PubMed ID: 23842827)
1. Systematic review and meta-analysis of additional technologies to enhance angioplasty for infrainguinal peripheral arterial occlusive disease.
Simpson EL; Michaels JA; Thomas SM; Cantrell AJ
Br J Surg; 2013 Aug; 100(9):1128-37. PubMed ID: 23842827
[TBL] [Abstract][Full Text] [Related]
2. Enhancements to angioplasty for peripheral arterial occlusive disease: systematic review, cost-effectiveness assessment and expected value of information analysis.
Simpson EL; Kearns B; Stevenson MD; Cantrell AJ; Littlewood C; Michaels JA
Health Technol Assess; 2014 Feb; 18(10):1-252. PubMed ID: 24524731
[TBL] [Abstract][Full Text] [Related]
3. Intravascular brachytherapy for peripheral vascular disease.
Andras A; Hansrani M; Stewart M; Stansby G
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003504. PubMed ID: 24399686
[TBL] [Abstract][Full Text] [Related]
4. Drug eluting balloons.
Diehm NA; Hoppe H; Do DD
Tech Vasc Interv Radiol; 2010 Mar; 13(1):59-63. PubMed ID: 20123434
[TBL] [Abstract][Full Text] [Related]
5. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
[TBL] [Abstract][Full Text] [Related]
6. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of enhancements to angioplasty for infrainguinal arterial disease.
Kearns BC; Michaels JA; Stevenson MD; Thomas SM
Br J Surg; 2013 Aug; 100(9):1180-8. PubMed ID: 23842832
[TBL] [Abstract][Full Text] [Related]
8. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
[TBL] [Abstract][Full Text] [Related]
9. Randomized trials for endovascular treatment of infrainguinal arterial disease: systematic review and meta-analysis (Part 2: Below the knee).
Jens S; Conijn AP; Koelemay MJ; Bipat S; Reekers JA
Eur J Vasc Endovasc Surg; 2014 May; 47(5):536-44. PubMed ID: 24650395
[TBL] [Abstract][Full Text] [Related]
10. Restenosis Prevention With Drug Eluting or Covered Stents in Femoropopliteal Arterial Occlusive Disease: Evidence From a Comprehensive Network Meta-analysis.
He R; Ye Y; Li Z; Jiang Y; Li Y; Liu Y; Wang K; Yao C
Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):61-74. PubMed ID: 31202582
[TBL] [Abstract][Full Text] [Related]
11. In-stent restenosis: mid-term results of debulking using excimer laser and drug-eluting balloons: sustained benefit?
van den Berg JC; Pedrotti M; Canevascini R; Chimchila Chevili S; Giovannacci L; Rosso R
J Invasive Cardiol; 2014 Jul; 26(7):333-7. PubMed ID: 24993991
[TBL] [Abstract][Full Text] [Related]
12. Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany.
Pietzsch JB; Geisler BP; Garner AM; Zeller T; Jaff MR
Catheter Cardiovasc Interv; 2014 Oct; 84(4):546-54. PubMed ID: 24782424
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of drug-eluting stents in patients with acute ST-segment-elevation myocardial infarction: a meta-analysis of randomized controlled trials.
Hao PP; Chen YG; Wang XL; Zhang Y
Tex Heart Inst J; 2010; 37(5):516-24. PubMed ID: 20978561
[TBL] [Abstract][Full Text] [Related]
14. Evolving modalities for femoropopliteal interventions.
Ansel GM; Lumsden AB
J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
[TBL] [Abstract][Full Text] [Related]
15. Below-the-knee revascularization. Advanced techniques.
SCHWARZWALDER U; ZELLER T
J Cardiovasc Surg (Torino); 2009 Oct; 50(5):627-34. PubMed ID: 19741578
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial.
Zeller T; Baumgartner I; Scheinert D; Brodmann M; Bosiers M; Micari A; Peeters P; Vermassen F; Landini M; Snead DB; Kent KC; Rocha-Singh KJ;
J Am Coll Cardiol; 2014 Oct; 64(15):1568-76. PubMed ID: 25301459
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel Drug-Eluting Stents in Peripheral Arterial Disease: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2015; 15(20):1-62. PubMed ID: 26719778
[TBL] [Abstract][Full Text] [Related]
18. Peripheral drug-eluting technology.
Franzone A; Stabile E; Trimarco B; Esposito G
Cardiol Clin; 2015 Feb; 33(1):151-62. PubMed ID: 25439337
[TBL] [Abstract][Full Text] [Related]
19. Mortality in patients undergoing revascularization with paclitaxel eluting devices for infrainguinal peripheral artery disease: Insights from a network meta-analysis of randomized trials.
Kuno T; Ueyama H; Mikami T; Takagi H; Numasawa Y; Anzai H; Bangalore S
Catheter Cardiovasc Interv; 2020 Oct; 96(4):E467-E478. PubMed ID: 32691953
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
